Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its new ProPak™ GMP cytokines, alongside its portfolio of innovative products and solutions supporting cell and gene therapy ...

TOPLINE: Sjögren disease (SjD) presents three distinct phenotypes ― B-cell active with low symptom burden, high systemic ...

ScaleReady, in collaboration with Wilson Wolf Manufacturing and Bio-Techne Corporation, today announced that Seattle Children ...

Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may ...

In a large-animal model study, researchers have found that heart attack recovery is aided by the injection of heart muscle ...

NSW Health advises HMPV is prone to resolving within one to 10 days of infection. Unlike Covid, the average person is likely ...

Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...

In a significant advancement for cancer research, a team of scientists from Max Planck Institute for Biology Tübingen, ...

Qkine in Cambridge has joined forces with Australian company Culturon to deliver cutting-edge solutions for multiple elements ...

According to Celltrion, STEQEYMA is expected to be marketed in the United States beginning in February 2025. DISCLAIMER: Because of the generality of this update, the information provided herein may ...

A new study puts an estimate on the global number of cases of type 2 diabetes and cardiovascular disease caused by the sugary ...

Neither coffee drinking pattern was tied to more or less cancer-specific mortality.